Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.

NCT00698646 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

384

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Valsartan + HCTZ
DRUG: Valsartan
DRUG: HCTZ

Sponsor

Novartis Pharmaceuticals